Clinical trial
SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease. A Prospective Multicenter Follow-up Protocol With a Nested Randomized Controlled Trial of Physical Education Benefits - The SEDKID Study
NCT06935786 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease. A Prospective Multicenter Follow-up Protocol With a Nested Randomized Controlled Trial of Physical Education Benefits - The SEDKID Study
- Lead sponsor
- Turku University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 21, 2025
- Completion date
- December 31, 2031
- Enrollment
- 400 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, chronic kidney disease, frailty